TABLE 3.

Susceptibilities of yeasts other than C. albicans to fluconazole as determined by NCCLS broth macrodilution testing

Patient no.	Organism	No. of visits	Fluconazole MIC (μg/ml)
			24 h	48 h
1a	C. dubliniensis	5	≤0.125–0.25	≤0.125–0.5
2a	C. rugosa	3	4	4–8
7	C. glabrata	2	1–16	1–16
	C. tropicalis	1	2–64	4–64
10	C. kefyr	4	≤0.125–0.25	0.25–1
11a	C. krusei	3	16	32–64
13	C. glabrata	5	2–32	8–64
	C. krusei	4	32	>64
	C. famata	2	0.25	0.5–1
14	C. glabrata	7	2–32	8–64
	Saccharomyces cerevisiae	2	0.5–4	1–8
15	C. krusei	3	16	32–64
19	C. krusei	2	64	>64
	Hansenula anomala	1	1–2	1–2
24a	S. cerevisiae	6	2–4	4
27	C. glabrata	3	4	16–64
	C. krusei	3	32	64
28	Cryptococcus albidus	1	16–32	>64
29	C. krusei	4	8–32	16–64

^aThe patient experienced clinical infection.